ArticleInternational journal of obesity (2005)2016

Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.

L Aagaard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.